These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 355604

  • 1. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
    Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA.
    J Neurosurg; 1978 Sep; 49(3):333-43. PubMed ID: 355604
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
    Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA.
    N Engl J Med; 1980 Dec 04; 303(23):1323-9. PubMed ID: 7001230
    [Abstract] [Full Text] [Related]

  • 4. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S, Brain Tumor Cooperative Group.
    Neurosurgery; 2002 Aug 04; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC, Gaspar L, Imperato J, Salter M, Herndon J, Dowling S.
    Am J Clin Oncol; 1993 Aug 04; 16(4):277-83. PubMed ID: 8392285
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
    Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB.
    J Neurosurg; 1985 Aug 04; 63(2):218-23. PubMed ID: 2991486
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F, Prados M, Russell C, Weissman D, Evans R, Cook P, Burton G, Eisenberg PD, Valenzuela R, Verkh L.
    J Neurooncol; 1997 Mar 04; 32(1):45-55. PubMed ID: 9049862
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of mithramycin in the treatment of anaplastic gliomas.
    Walker MD, Alexander E, Hunt WE, Leventhal CM, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA.
    J Neurosurg; 1976 Jun 04; 44(6):655-67. PubMed ID: 178838
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.
    Nelson DF, Diener-West M, Horton J, Chang CH, Schoenfeld D, Nelson JS.
    NCI Monogr; 1988 Jun 04; (6):279-84. PubMed ID: 3281031
    [Abstract] [Full Text] [Related]

  • 17. Interferon as adjuvant therapy with initial radiotherapy of patients with anaplastic gliomas.
    Mahaley MS, Urso MB, Whaley RA, Williams TE, Guaspari A.
    J Neurosurg; 1984 Dec 04; 61(6):1069-71. PubMed ID: 6209367
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
    Weller M, Müller B, Koch R, Bamberg M, Krauseneck P, Neuro-Oncology Working Group of the German Cancer Society.
    J Clin Oncol; 2003 Sep 01; 21(17):3276-84. PubMed ID: 12947063
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y, Abe H, Suzuki J, Tanaka R, Kitamura K, Miwa T, Matsutani M, Takeuchi K, Takakura K, Nomura K.
    No To Shinkei; 1985 Oct 01; 37(10):999-1006. PubMed ID: 3000412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.